Nath Biogene India Ltd. — Call Transcript 2025

Apr 24, 2025

==> picture [188 x 86] intentionally omitted <==

24[th] April 2025

The Manager-Listing The Manager-Listing

BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Bandra (E) Mumbai-400001 Mumbai-400051

BSE Code-537291 NSE Code-NATHBIOGEN

Dear Sirs,

Subject- Intimation of Earning Conference Call.

This is to inform that the Company will hold Earning Conference Call on Wednesday, 30[th] April 2025 at 04:00 PM IST.

Please find attached herewith the Conference Call Dial in Information.

Thanking You

For Nath Bio-Genes (India) Limited

Digitally signed by Amol Arunrao Amol Arunrao Gupta Gupta Date: 2025.04.24 10:50:03 +05'30'

Amol Gupta Chief Financial Officer

==> picture [452 x 36] intentionally omitted <==

==> picture [105 x 58] intentionally omitted <==

==> picture [81 x 55] intentionally omitted <==

Nath Bio-Genes (I) Limited Q4 & FY25 Earnings Conference Call

Hosted by Go India Advisors

On Wednesday, April 30, 2025 04:00 PM IST

Company Participants

Mr. Satish Kagliwal Managing Director Mr. Devinder Khurana Executive Vice President

Mr. Amol Gupta Chief Financial Officer Mr. Harish Pandey Sales Lead Mr. Venkatesh Kulkarni Research Lead

Call in Details:

Pre-register to avoid wait time, join with Diamond Pass.

Registration link: CLICK HERE

Dial in Numbers: Please dial-in at least 5-10 minutes prior to the conference call schedule to ensure that you are connected to the call on time

Universal Dial-In Number

+91 22 6280 1557/ +91 22 7115 8383

For further information, kindly contact:

Deepika Sharma Sheetal Khanduja deepika@goindiaadvisors.com sheetal@goindiaadvisors.com